Hematology Reports (Feb 2025)

Factor X Concentrate Treatment Schedule and Dosing in Acquired FX Deficiency

  • Andrew Ross,
  • Rebecca J. Shaw,
  • Louise Garth,
  • Cathy Farrelly

DOI
https://doi.org/10.3390/hematolrep17020010
Journal volume & issue
Vol. 17, no. 2
p. 10

Abstract

Read online

Background: Acquired factor X (FX) deficiency is a rare condition that can cause life threatening bleeding. Here we outline a successful management strategy for gastrointestinal bleeding (GI) using human FX concentrate. Case description: A 61-year-old male presented with upper GI bleeding and a prolonged prothrombin time. Investigations demonstrated an acquired FX deficiency (determined to be secondary to AL amyloidosis). Results: Treatment with FX concentrate to maintain trough FX levels >20% resulted in successful cessation of bleeding symptoms, and levels >50% facilitated urgent invasive procedures. Conclusions: This case report adds valuable insight into the management of this rare condition, and how best to utilize FX concentrates in acquired FX deficiency.

Keywords